Eli Lilly and Company

Docketing Associate

United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, PharmaceuticalsIndustries

Requirements

Candidates must possess a high school diploma or GED and at least three years of progressive experience in a Patent and Trademark Docketing support role. Qualified applicants must be authorized to work in the United States full-time, as Lilly will not provide work authorization or visa sponsorship. Proficiency in Outlook, Internet Explorer, MS Office programs, legal software, or docketing programs like Anaqua is required. Experience in the pharmaceutical or healthcare industry, managing a large IP portfolio in a fast-paced setting, and understanding docketing best practices are preferred. Familiarity with formality documents, US, EP, and PCT patent rules, and electronic research tools is also beneficial.

Responsibilities

The Docketing Associate will proactively manage patent and trademark dockets throughout their lifecycle, including prosecution, filing, and maintenance. This role involves coordinating with internal and external legal professionals to ensure seamless operations and improve departmental best practices. Responsibilities include anticipating and researching complex issues, troubleshooting, problem-solving, and producing reliable work product. The associate will integrate with peers and business units, communicate support needs, and lead small projects or guide complex patent/trademark activities. They will also assess the impact of industry changes on departmental strategies and manage priorities effectively, interacting with various stakeholders including inventors, clients, and international law firms.

Skills

Docketing
Patent Prosecution
Trademark Prosecution
Legal Operations
Intellectual Property
Problem-Solving
Communication
Collaboration

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI